Significance of Staphylococcus lugdunensis Bacteremia: Report of 28 Cases and Review of the Literature by Zinkernagel, A. et al.
Significance of Staphylococcus lugdunensis
Bacteremia: Report of 28 Cases and Review
of the Literature
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Abstract
Background: Staphylococcus lugdunensis endocarditis has
been associated with an aggressive course. The aim of this
study was to determine factors associated with the develop-
ment of endocarditis in patients with S. lugdunensis bacter-
emia.
Methods: A retrospective analysis of all patients with
S. lugdunensis bacteremia in three tertiary care centers in
Switzerland was performed. Data regarding medical history,
symptoms, and susceptibility of S. lugdunensis isolates were
collected. Our results were reviewed in the context of the
current literature.
Results: A total of 28 patients with S. lugdunensis bacter-
emia were identified. Of the 13 patients with endocarditis,
all were community acquired. Cardiac surgery was performed
in 85% of these patients; mortality was 23%, reflecting the
aggressive course of this disease. In contrast, in the 15
patients without endocarditis, no complications associated
with S. lugdunensis bacteremia were observed. In 73%, a
probable source was identified in the form of a venous
catheter or other foreign device. Only three of these epi-
sodes were community acquired. No difference was observed
in susceptibility of the S. lugdunensis isolates to penicillin,
which was 77% in endocarditis isolates, and 87% in isolates
of bacteremia without endocarditis, respectively.
Conclusion: S. lugdunensis bacteremia is associated
with endocarditis in up to 50% of patients. Every patient
with community-acquired S. lugdunensis bacteremia should
be carefully examined for signs of endocarditis. Once
S. lugdunensis endocarditis is diagnosed, close monitoring
is essential and surgical treatment should be considered
early. In the nosocomial setting, endocarditis is far less
frequent, and S. lugdunensis bacteremia is usually associ-
ated with a catheter or other foreign materials.
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Introduction
Staphylococcus lugdunensis is a Gram-positive, coagulase
negative staphylococcus (CoNS) that was first described in
1988 [1, 2]. The organism is found as a skin commensal in
healthy individuals. S. lugdunensis has been implicated in
invasive diseases, especially fulminant native and pros-
thetic-valve endocarditis [3, 4]. Other invasive infections
include brain abscess and meningitis, skin abscesses
and soft tissue infections, spondylodiscitis, foreign body
infections, and peritonitis [5–8]. Since the initial case of
endocarditis was described in 1989 [9], over 60 cases of
endocarditis due to S. lugdunensis have been published in
the English literature [10, 11]. It is a feared entity since its
course can be very aggressive compared to other CoNS
and even Staphylococcus aureus. However, the clinical
significance of S. lugdunensis bacteremia remains unclear.
So far, only one retrospective review of all S. lugdunensis
bacteremias in a single center was done documenting
21 cases over a 10-year period [12]. In this center,
S. lugdunensis in the blood was not associated with com-
plications or death, and only six patients were considered
to have a clinically significant bacteremia. Of these, only
one had a possible endocarditis [12]. Two studies exam-
ined consecutive clinical isolates of S. lugdunensis. Blood
was the source in 15% and 9.7%, respectively [5, 13].
Clinical information was not available for all blood-derived
isolates, but endocarditis was not uniformly present.
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To evaluate factors associated with the risk of devel-
oping endocarditis, we retrospectively analyzed the case
histories of all patients with at least one blood culture
positive for S. lugdunensis from December 1996 until
December 2005 at three large tertiary care hospitals in
Switzerland. The clinical presentation, treatment, and
outcome of these patients were evaluated.
Methods
Patient Population
The microbiological records of all S. lugdunensis, S. aureus, and
CoNS blood isolates included in the computerized data base of
the microbiology laboratories of three tertiary care hospitals
(University Hospitals Zurich and Berne, and Triemli-Hospital, a
large University-affiliated community hospital in Zurich) were
reviewed and those with one or more blood cultures positive for
S. lugdunensis were further analyzed. The time frame was
December 1996 until December 2005 for the University Hospital
of Zurich, October 2000 until September 2005 for the University
Hospital of Berne and January 2001 until December 2005 for
the Triemli Hospital. All medical records of the patients with
S. lugdunensis bacteremia were retrieved and systematically
reviewed by an infectious disease specialist. Infective endocar-
ditis was diagnosed according to the Duke Criteria. The under-
lying diseases as well as the physical findings were reviewed, the
likely source for bacteremia and its consequences were deter-
mined, and the medical or surgical treatment received and
treatment outcome were examined. Nosocomial infection was
defined as occurrence of symptoms and diagnosis 48 h or more
after admission.
Microbiology
Blood cultures were performed using automatic systems (Bactec
9240, Becton Dickinson, Sparks, MD; and BacT/ALERT 3D,
bioMe´rieux, Marcy -l’Etoile, France). The identification of iso-
lates was performed using standard criteria and methods [14] or
automated miniaturized identification systems. The routine was
as follows: Division of Infectious Diseases, Triemli Hospital: All
staphylococcal isolates from blood cultures were tested for
clumping factor by latex agglutination test and for free coagulase
by a tube-coagulase-test. All isolates occurring in two or more
blood cultures or concomittantly in blood and on central venous
catheters were differentiated to the species level. Species iden-
tification was based on morphology and biochemical identifica-
tion with a commercial reagent-strip system (ID 32 Staph, Bio
Me´rieux) or Vitek2 card for Gram-positive cocci (Vitek 2, Bio-
Me´rieux). Susceptibility testing of S. lugdunensis was performed
by disk diffusion according to Clinical and Laboratory Standards
Institute guidelines. In addition, penicillin susceptibility was
determined by a disk-test for the production of b-lactamase
(Cefinase, Becton Dickinson) and confirmed with a susceptible
MIC by E-Test(AB Biodisk). Institute of Medical Microbiology,
Zurich: Staphylococci from blood cultures were tested for
clumping factor by a latex agglutination test (Staphaurex Plus;
Murex Diagnostics Ltd., Dartford, England). Clumping factor
positive isolates were further tested for the coagulase. Clumping
factor and coagulase-positive staphylococci were identified as S.
aureus, whereas clumping factor positive, coagulase negative
staphylococci were identified as S. lugdunensis by a positive
ornithine decarboxylase and pyrrolidonyl peptidase or differen-
tiated to the species level by commercial identification systems
[14]. Furthermore, clumping factor negative staphylococci, with a
morphology suggestive of S. aureus or S. lugdunensis, were dif-
ferentiated to the species level by commercial systems (ID 32
Staph, Bio Me´rieux) or Vitek2 card for Gram-positive cocci
(Vitek 2, BioMe´rieux). The advantage of this particular test
(Staphaurex Plus; Murex Diagnostics Ltd., Dartford, England) is
its excellent sensitivity for S. lugdunensis [15]. Institute for
Infectious Diseases, Bern: All isolates having a colony mor-
phology and/or susceptibility pattern consistent with S. lugdun-
ensis, or with a positive clumping factor but negative tube
coagulase test, were further tested to confirm/refute the putative
identification of S. lugdunensis. For resistance testing, the disk
diffusion method according to the Clinical and Laboratory
Standards Institute guidelines was used.
Literature Review
The existing English literature on S. lugdunensis bacteremia and
endocarditis was identified through a Medline search (1980 to
present) using the terms ‘‘S. lugdunensis’’, ‘‘bacteremia’’,
‘‘endocarditis’’, as well as common abbreviations thereof.
Results
Twenty-eight patients with S. lugdunensis bacteremia
were identified. Thirteen patients were diagnosed with
endocarditis, 15 had S. lugdunensis bacteremia without
endocarditis. All patients with endocarditis had between 2
and 16 blood cultures positive for S. lugdunensis upon
hospital admission (Table 1). The two clinical major Duke
criteria (positive echocardiography, positive blood cul-
ture) were fulfilled in all but one patient, confirming
definite endocarditis. In the remaining patient, endocar-
ditis was confirmed by autopsy after the death of the
patient. In five endocarditis patients, a possible source of
infection was found: a gluteal abscess, a wound after a
bicycle fall, and a pacemaker in one each, and intravenous
drug abuse in two. All endocarditis cases were community
acquired. Septic emboli were seen in seven (54%)
patients. Cardiac surgery with either valve replacement
and or reconstruction was performed in 11 out of 13
(85%) patients with endocarditis. Three out of thirteen
(23%) patients died due to complications related to the
endocarditis and all three had been treated surgically.
S. lugdunensis bacteremia in the 15 patients without
endocarditis did not result in any complications related to
bacteremia. In these patients, 1–5 blood cultures were
positive. All these patients had preexisting relevant com-
orbidities as outlined in Table 2. A probable source could
be identified in 13 patients (87%), and was catheter or
foreign device-related in 11 patients (73%). All but three
episodes were of nosocomial origin. The two deaths
occurring in this patient group were caused by the
underlying illness and were not related to S. lugdunensis
bacteremia.
Female to male ratio was 1:3 in both groups. Mean
age was 60 years (range 34–77) in the endocarditis group,
and 52 years (range 25–67) in the bacteremia-alone group.
The time of onset of clinical symptoms until treatment
initiation was shorter for the patient group without
endocarditis (mean 1 week [range 1–3]) as compared to
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patients with endocarditis (mean 3 weeks [range 1–8]). In
the endocarditis group, 77% of isolates were penicillin
susceptible, as compared to 87% in the bacteremia group
without endocarditis.
Discussion
In this retrospective analysis, 28 patients with S. lugdun-
ensis bacteremia were identified in three tertiary-care
hospitals over a period of 4–9 years. Analysis of the
clinical course enabled the characterization of two main
patterns. Thirteen of the 28 patients (46%) presented
with definite endocarditis, according to the Duke criteria
(Table 1). In this group, infection with S. lugdunensis was
generally community-acquired and was responsible for a
severe course. Despite aggressive treatment, including
surgical intervention, mortality attributable to S. lugdunensis
was high. Comorbidity with a potential relation to the
development of endocarditis was present in 7 of the 13
patients.
In contrast, none of the 15 patients without endocar-
ditis experienced complications of S. lugdunensis bacter-
emia. Except in three cases, the infection was acquired
nosocomially, and a probable source was identifiable in 13
patients (87%; Table 2).
These observations help to reconcile some seemingly
conflicting data. Ebright et al. published a series of patients
with S. lugdunensis bacteremia. Out of 21 episodes, only six
were considered to be clinically relevant, and endocarditis
was found in only one patient. It was recognized early,
however, that S. lugdunensis endocarditis could follow a
very aggressive course and was associated with a high
mortality. Since the first series of cases of S. lugdunensis
endocarditis was described by Vandenesch et al. [16], the
severe nature of this entity has been confirmed in several
small series and single case reports.
Our data demonstrate that if S. lugdunensis occurs
without endocarditis, it is usually associated with nosoco-
mial acquisition, a central venous access, and a benign
course. S. lugdunensis bacteremia probably occurs more
frequently than identified. Except for the paper mentioned
above, only early reports have looked at non-valvular
S. lugdunensis infections. Besides this reporting bias, spe-
cies identification of CoNS is not done routinely, or might
misidentify S. lugdunensis as S. aureus due to similarity in
colony-morphology and a positive test for the clumping
factor. Foreign material-related infection with S. lugdun-
ensis can be difficult to eradicate, if the foreign device is not
removed. In a patient with pacemaker-associated infection
with a small colony variant of S. lugdunensis, the infection
was only cleared after removal of the pacemaker, despite
repeated courses of antibiotic therapy of a fully susceptible
strain [6].
In the group with S. lugdunensis endocarditis, the
clinical characteristics and course were comparable to
those reported in the literature. The surgical rate was high
(85%), reflecting either an aggressive disease course or a
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more aggressive approach by the treating physicians.
Mortality was 23%. Both the two patients without surgery
had isolated mitral valve disease recovered. In the analysis
by Anguera et al. [10], left-sided endocarditis and multi-
valvular involvement was associated with an increased
need for surgery. In their review of all documented cases
of S. lugdunensis endocarditis, surgery was performed in
51% of all patients, and overall mortality was 42%. They
compared surgical rates and mortality for S. aureus and
CoNS endocarditis occurring in the same time frame at
their institution, and found a surgical rate of 36.9% and
54%, respectively. Mortality was 14.5% for S. aureus and
23.5% for CoNS (including S. lugdunensis) endocarditis
[10]. In a large overview including 558 patients with def-
inite S. aureus endocarditis, surgery was performed in
37.8%, and overall mortality was 22.4%. Stroke (21.3%),
or systemic embolization (27.1%) occurred less frequently
than in our collective (77%) [17]. Taken together, these
data and our own experience indicate that S. lugdunensis
endocarditis follows a more aggressive and complicated
course, even when compared to S. aureus endocarditis.
The high virulence is also reflected in the high rate of
endocarditis (46%) of all patients with S. lugdunensis
bacteremia. In S. aureus bacteremia, underlying endo-
carditis was found in a range from 7% to 34%, depending
on the risk factors present [18, 19].
The majority of our isolates (23 of 28, 82%) were
penicillin susceptible. Of the five isolates resistant to
penicillin, none were resistant to oxacillin or multiresis-
tant. This is in accordance with the series of Anguera
et al., where most of the strains were penicillin suscepti-
ble. However, no further details were given. In contrast, in
the analysis by Ebright et al. [12], up to 25% of all isolates
were resistant to multiple antibiotics, including oxacillin.
It is important to note that with S. lugdunensis, low-level
oxacillin resistance is not indicative of the mecA gene [20].
The mecA gene has only rarely been detected in oxacillin-
resistant S. lugdunensis [21]. Disk testing may falsely
indicate oxacillin resistance, and it is recommended that
S. lugdunensis isolates with an MIC > 0.5 lg/ml should be
screened for the presence of either the mecA gene or PBP
2a [12, 22]. The newer guidelines propose using cefoxitin
to test methicillin resistance in S. lugdunensis, and the
breakpoints for oxacillin is now equal for S. aureus and
S. lugdunensis [23]. False-positive b-lactamase results with
S. lugdunensis in automated systems have been described,
further complicating adequate resistance testing [24].
Antibiotic treatment for S. lugdunensis does not differ
from the regimens used for other coagulase-negative
staphylococci or S. aureus. Important factors to consider,
among others, are the susceptibility pattern and the
question whether a native or prosthetic valve is affected.
S. aureus and S. lugdunensis show both a complete
hemolysis and a yellow pigmentation which appears earlier
and stronger in S. aureus; colonies of S. lugdunensis are
slightly yellow pigmented after 2 days and pale yellow to
golden after 3–5 days [14], but are negative for the tube
coagulase test. Detailed identification to the species level
should be obtained from positive blood cultures if the
multiple isolated coagulase-negative staphylococcus is only
resistant to penicillin or even totally susceptible. The cli-
nician should be aware that the diagnosis of S. lugdunensis
remains difficult. S. lugdunensis expresses the fibrinogen
affinity factor (clumping factor), which is primarily detected
by rapid agglutination tests for the identification of S. aureus
[14]. S. lugdunensis with a positive clumping factor can be
misidentified as S. aureus if the tube coagulase test is not
simultaneously performed. If a very aggressive form of
staphylococcal endocarditis is encountered, the possibility
of S. lugdunensis infection should be kept in mind.
Including only those patients with S. lugdunensis
bacteremia allowed demonstrating the specific clinical and
epidemiological patterns of patients with and without
endocarditis. However, an important limitation of our
study is its retrospective nature. Although it is the gen-
eral policy of the three involved institutions to identify
S. lugdunensis from isolates of CoNS if they occur in
blood cultures or are deemed clinically relevant, the
true prevalence of bacteremia might be underestimated.
Further, as the data presented are from tertiary care
centers, a referral bias might be present.
The reasons for the very different clinical course of
foreign material-associated S. lugdunensis infection and
endocarditis are not known. It has been postulated that
contrary to other CoNS, S. lugdunensis shares a number of
potential virulence factors with S. aureus. In particular,
S. lugdunensis may express a clumping factor and/or
produce a thermostable DNase [25]. Additional factors
may contribute to its pathogenic potential [25]. It is likely,
that both host factors and specific virulence factors of the
pathogen must interplay to result in severe infection of the
normal host, such as endocarditis. In patients with an
impaired barrier due to foreign material, catheters or
wounds, the threshold for infection is lowered; however,
its course is usually milder and can be controlled by
appropriate measures such as antibiotic therapy and
restoring integrity/removal of foreign material.
In conclusion, S. lugdunensis bacteremia is associated
with endocarditis in up to 50% of patients. Every patient
with community-acquired S. lugdunensis bacteremia
should be carefully examined for the presence of endo-
carditis. Once S. lugdunensis endocarditis is diagnosed,
close monitoring is essential and surgical treatment should
be considered early. In the nosocomial setting, endocarditis
is far less frequent, and S. lugdunensis bacteremia is usually
associated with a catheter or other foreign material.
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